Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Martha Chekenya Enger"'
Publikováno v:
Cancer Research. 77:LB-195
Introduction: Glioblastoma (GBM) is the most aggressive and lethal brain cancer in adults where best available therapy combining surgery and concomitant chemo radiation prolongs patient survival from 12.1 to 14.6 months. Approximately half of the pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d798e7342bed888a2e20d67cae33c7e
https://doi.org/10.1158/1538-7445.am2017-lb-195
https://doi.org/10.1158/1538-7445.am2017-lb-195
Autor:
Daniel Stieber, TK Olsen, Per Øyvind Enger, Anders Molven, Simone P. Niclou, Agnete Svendsen, Rolf Bjerkvig, Anja Torsvik, Bengt Westermark, Martha Chekenya Enger, Anna Golebiewska
Publikováno v:
Cancer Medicine
It is well known that in vitro subculture represents a selection pressure on cell lines, and over time this may result in a genetic drift in the cancer cells. In addition, long-term cultures harbor the risk of cross-contamination with other cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d40d076175c389606e521480621af40
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-245563
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-245563
Autor:
Mateusz Zelkowski, Per Øyvind Enger, Andrea Gras Navarro, Martha Chekenya Enger, Justyna Kmiecik, Jacques Zimmer
Publikováno v:
Cancer Research. 73:LB-332
Glioblastoma (GBM) is the most malignant and frequent brain tumor. Despite combined surgery, chemo- and radiotherapy, GBM patients' survival remains very low, emphasizing the need for further development of novel therapies. The promising strategy is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::766576fad285f41b906fb4f4207662c8
https://doi.org/10.1158/1538-7445.am2013-lb-332
https://doi.org/10.1158/1538-7445.am2013-lb-332